Journal of Clinical Epidemiology
Volume 59, Issue 8 , Pages 784-790 , August 2006

A review finds that multicenter studies face substantial challenges but strategies exist to achieve Institutional Review Board approval

  • Sarah M. Greene

      Affiliations

    • Group Health Cooperative Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA
    • Corresponding Author InformationCorresponding Author. Tel.: 206-287-2989; fax: 206-287-2871.
    • ,
  • Ann M. Geiger

      Affiliations

    • Wake Forest University School of Medicine, Department of Public Health Sciences, Section on Social Sciences and Health Policy Medical Center Blvd, Winston-Salem, NC 27157

,Accepted 19 November 2005.

References 

  1. Title 45 Code of Federal Regulations; Part 46. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm.
  2. Silverman H, Hull SC, Sugarman J. Variability among institutional review boards' decisions within the context of a multicenter trial. Crit Care Med. 2001;29:235–241
  3. Office of the Inspector General. Institutional Review Boards. A time for reform. 1998. Available at http://www.oig.hhs.gov/oei/reports/oei-01-97-00193.pdf.
  4. Emanuel EJ, Wood A, Fleischman A, Bowen A, Getz KA, Grady C, et al. Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med. 2004;141:282–291
  5. Dockerty JD, Elwood M. The difficulties and costs of ethical assessment of a national research project. N Z Med J. 1992;105:311–313
  6. Roberts LM, Bowyer L, Homer CS, Brown MA. Multicentre research: negotiating the ethics approval obstacle course. Med J Aust. 2004;180:139
  7. Schneider EC, Epstein AM, Malin JL, Kahn KL, Emanuel EJ. Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. J Clin Oncol. 2004;22:2985–2991
  8. Tully J, Ninis N, Booy R, Viner R. The new system of review by multicentre research ethics committees: prospective study. BMJ. 2000;320:1179–1182
  9. Vick CC, Finan KR, Kiefe C, Neumayer L, Hawn MT. Variation in Institutional Review processes for a multisite observational study. Am J Surg. 2005;190:805–809
  10. Green LA, Lowery JC, Kowalski CP, Wyszewianski L. Impact of institutional review board practice variation on observational health services research. Health Serv Res (released electronically prior to publication).
  11. Humphreys K, Trafton J, Wagner TH. The cost of institutional review board procedures in multicenter observational research. Ann Intern Med. 2003;139:77
  12. Lux AL, Edwards SW, Osborne JP. Responses of local research ethics committees to a study with approval from a multicentre research ethics committee. BMJ. 2000;320:1182–1183
  13. Ah-See KW, MacKenzie J, Thakker NS, Maran AG. Local research ethics committee approval for a national study in Scotland. J R Coll Surg Edinb. 1998;43:303–305
  14. Ahmed AH, Nicholson KG. Delays and diversity in the practice of local research ethics committees. J Med Ethics. 1996;22:263–266
  15. Burman W, Breese P, Weis S, Bock N, Bernardo J, Vernon A. The effects of local review on informed consent documents from a multicenter clinical trials consortium. Control Clin Trials. 2003;24:245–255
  16. Dal Re R, Espada J, Ortega R. Performance of research ethics committees in Spain. A prospective study of 100 applications for clinical trial protocols on medicines. J Med Ethics. 1999;25:268–273
  17. Dziak K, Anderson R, Sevick MA, Weisman CS, Levine DW, Scholle SH. Variations among Institutional Review Board reviews in a multisite health services research study. Health Serv Res. 2005;40:279–290
  18. Greene SM, Geiger AM, Harris EL, Altschuler A, Nekhlyudov L, Barton MB, Rolnick SJ, Elmore JG, Fletcher S. Impact of IRB Requirements on a multicenter survey of prophylactic mastectomy outcomes. Ann Epidemiol (released electronically prior to publication).
  19. Hirshon JM, Krugman SD, Witting MD, Furuno JP, Limcangco MR, Perisse AR, et al. Variability in institutional review board assessment of minimal-risk research. Acad Emerg Med. 2002;9:1417–1420
  20. Larson E, Bratts T, Zwanziger J, Stone P. A survey of IRB process in 68 U.S. hospitals. J Nurs Scholarsh. 2004;36:260–264
  21. McNay LA, Tavel JA, Oseekey K, McDermott CM, Mollerup D, Bebchuk JD. Regulatory approvals in a large multinational clinical trial: the ESPRIT experience. Control Clin Trials. 2002;23:59–66
  22. McWilliams R, Hoover-Fong J, Hamosh A, Beck S, Beaty T, Cutting G. Problematic variation in local institutional review of a multicenter genetic epidemiology study. JAMA. 2003;290:360–366
  23. Redshaw ME, Harris A, Baum JD. Research ethics committee audit: differences between committees. J Med Ethics. 1996;22:78–82
  24. Sarson-Lawrence M, Alt C, Mok MT, Dodds M, Rosenthal MA. Trust and confidence: towards mutual acceptance of ethics committee approval of multicentre studies. Intern Med J. 2004;34:598–603
  25. Stair TO, Reed CR, Radeos MS, Koski G, Camargo CA. Variation in institutional review board responses to a standard protocol for a multicenter clinical trial. Acad Emerg Med. 2001;8:636–641
  26. Boyce M. Observational study of 353 applications to London multicentre research ethics committee 1997–2000. BMJ. 2002;325:1081
  27. Collins JF, Garg R, Teo KK, Williford WO, Howell CL. The role of the data coordinating center in the IRB review and approval process: the DIG trial experience. Control Clin Trials. 2003;24:306S–315S
  28. Kornetsky S. IRB Review of Multicenter Trials: How can we improve? Available at: http://hhs.gov/ohrp/sachrp/mtgings/mtg10-04/present/korn1_files/frame.htm.
  29. Oakes JM. Risks and wrongs in social science research. An evaluator's guide to the IRB. Eval Rev. 2002;26:443–479
  30. Thornquist MD, Edelstein C, Goodman GE, Omenn GS. Streamlining IRB review in multisite trials through single-study IRB Cooperative Agreements: experience of the Beta-Carotene and Retinol Efficacy Trial (CARET). Control Clin Trials. 2002;23:80–86
  31. Evaluation of NIH implementation of Section 491 of the Public Health Service Act, mandating a program of protection for research subjects. Final Report. 1998;
  32. Sengupta S, Lo B. The roles and experiences of nonaffiliated and non-scientist members of institutional review boards. Acad Med. 2003;78:212–218
  33. Levine RJ, Lasagna L. Demystifying central review boards: current options and future directions. IRB. 2000;22:1–9
  34. Kent G. Responses by four Local Research Ethics Committees to submitted proposals. J Med Ethics. 1999;25:274–277
  35. Jamrozik K. The case for a new system for oversight of research on human subjects. J Med Ethics. 2000;26:334–339
  36. Gilman RH, Anderton C, Kosek M, Garcia HH, Evans CA. How many committees does it take to make a project ethical?. Lancet. 2002;360:1025–1026
  37. Prentice ED, Antonson DL. A protocol review guide to reduce IRB inconsistency. IRB. 1987;9:9–11
  38. Christian MC, Goldberg JL, Killen J, Abrams JS, McCabe MS, Mauer JK, et al. A central institutional review board for multi-institutional trials. N Engl J Med. 2002;346:1405–1408
  39. Committee on Assessing the System for Protecting Human Research Participants, Institute of Medicine. Responsible research: a systems approach to protecting research participants. Washington, DC: Academies Press; 2002. Available at: http://www.iom.edu/report.asp?id=4459.
  40. American Society of Clinical Oncology policy statement: oversight of clinical research. J Clin Oncol. 2003;21:2377–2386
  41. Report and recommendations of the National Bioethics Advisory Commission, Volume 1. Ethical and policy issues in research involving human participants. Bethesda, MD: National Bioethics Advisory Commission; 2001. Available at: www.georgetown.edu/research/nrcbl/nbac/human/overvol1.pdf.
  42. Burman WJ, Reves RR, Cohn DL, Schooley RT. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med. 2001;134:152–157
  43. Loh ED, Meyer RE. Medical schools' attitudes and perceptions regarding the use of central institutional review boards. Acad Med. 2004;79:644–651
  44. Office of the Inspector General. Institutional Review Boards: Promising approaches. Available at: http://oig.hhs.gov/oei/reports/oei-01-97-00191.pdf.
  45. Levine RJ. Institutional review boards: a crisis in confidence. Ann Intern Med. 2001;134:161–163
  46. Ghersi D, Campbell EG, Pentz R, Cox MC. The future of institutional review boards. Lancet Oncol. 2004;5:325–329
  47. Califf RM, Morse MA, Wittes J, Goodman SN, Nelson DK, DeMets DL, et al. Toward protecting the safety of participants in clinical trials. Control Clin Trials. 2003;24:256–271

PII: S0895-4356(06)00007-2

doi: 10.1016/j.jclinepi.2005.11.018

Journal of Clinical Epidemiology
Volume 59, Issue 8 , Pages 784-790 , August 2006

Article Tools